Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Precision Therapy Versus Standard Therapy in Acute Myeloid Leukaemia and Myelodysplastic Syndrome in Elderly

NCT05025098 is registered in ClinicalTrials.gov with University Hospital, Akershus as lead sponsor.

NCT NCT05025098
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05025098 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Precision Therapy Versus Standard Therapy in Acute Myeloid Leukaemia and Myelodysplastic Syndrome in Elderly
Lead sponsor
University Hospital, Akershus
Phase
Phase 2
Overall status
Recruiting
Start date
June 22, 2021
Completion date
June 10, 2027
Enrollment
36 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

aml, adult, mds